Trials / Unknown
UnknownNCT04554251
Global Impact of COVID-19 on Pulmonology Special Units
Global Impact of COVID-19 on Pulmonology Special Units (Bronchoscopy, Thoracoscopy, Ultrasonography and Sleep Lab)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The COVID-19 pandemic is having a profound impact on the world. As of May 18, 2020, there were 4,889,287 confirmed cases and 322,683 deaths globally. The healthcare system is wrestling with a virus that threatens to overwhelm hospital capacity, while simultaneously confronting an unprecedented reduction in elective and non-essential care. A survey by the American Cancer Society showed that 50% of cancer patients and survivors reported some impact to their healthcare due to the COVID-19 epidemic. A recent survey was conducted by Forbes et al to evaluate the changes in GI and endoscopy practices in North America. However, the impact of this epidemic on Pulmonology units ( bronchoscopy, thoracoscopy, ultrsonography and sleep lab) globally has not been studied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Survey | invited questionnaire |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-30
- First posted
- 2020-09-18
- Last updated
- 2020-09-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04554251. Inclusion in this directory is not an endorsement.